Paris, France

Beatriz Escribano Arenales

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sanofi-Aventis. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Beatriz Escribano Arenales. Retrieved from https://idiyas.com/inventor/beatriz-escribano-arenales

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Beatriz Escribano Arenales

Introduction:

Beatriz Escribano Arenales is a talented inventor based in Paris, France, with a passion for developing innovative solutions in the pharmaceutical industry. With an impressive patent under his belt, Beatriz is making waves in the field of medicinal chemistry.

Latest Patents:

Beatriz Escribano Arenales holds one patent for 'Isoquinoline and benzo[H] isoquinoline derivatives, preparation and therapeutic use thereof as antagonists of the histamine H3 receptor'. This invention revolves around a compound formula that shows promise as a medicament for disorders requiring modulation of the histamine H3 receptor.

Career Highlights:

Currently affiliated with Sanofi-Aventis, Beatriz Escribano Arenales demonstrates dedication and expertise in his work. His commitment to developing novel compounds for therapeutic purposes showcases his innovative mindset and scientific prowess.

Collaborations:

In his professional journey, Beatriz has collaborated with esteemed colleagues such as Juan Antonio Diaz Martin and Maria Dolores Jimenez Bargueno. Together, they contribute to the advancement of pharmaceutical research and the development of groundbreaking solutions.

Conclusion:

Beatriz Escribano Arenales's contributions to the field of medicinal chemistry are invaluable, with his patented invention paving the way for new treatment possibilities. His collaboration with industry experts underscores his commitment to innovation and excellence in pharmaceutical research. As Beatriz continues to push boundaries and explore new horizons, his impact on the industry is sure to be enduring and transformative.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…